Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
We report a case of anti-HMGCR myopathy mimicking limb-girdle muscular dystrophy in a 27-year-old male patient with no history of statin intake and presenting with a chronic onset form over 3 years. Treatment with prednisone and methotrexate was initiated with an insufficient response, so intravenou...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2021-06-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/2672 |
id |
doaj-d5a874346f7b4f559fccb83316447ffe |
---|---|
record_format |
Article |
spelling |
doaj-d5a874346f7b4f559fccb83316447ffe2021-07-08T07:42:22ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942021-06-0110.12890/2021_0026722288Chronic Onset Form of Anti-HMG-CoA Reductase MyopathyNoel Lorenzo Villalba0Emmanuel Andrés1Alain Meyer2Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasboug, FranceService de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasboug, FranceService de Rhumatologie, Hôpitaux Universitaires de Strasbourg, FranceWe report a case of anti-HMGCR myopathy mimicking limb-girdle muscular dystrophy in a 27-year-old male patient with no history of statin intake and presenting with a chronic onset form over 3 years. Treatment with prednisone and methotrexate was initiated with an insufficient response, so intravenous immunoglobulin was added. One year after initial treatment was started, as levels of creatine kinase (CK) were >1000 U/l, treatment with rituximab was added. Despite a 3-year delay before treatment, muscle strength improved even though CK levels remain elevated.https://www.ejcrim.com/index.php/EJCRIM/article/view/2672 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Noel Lorenzo Villalba Emmanuel Andrés Alain Meyer |
spellingShingle |
Noel Lorenzo Villalba Emmanuel Andrés Alain Meyer Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy European Journal of Case Reports in Internal Medicine |
author_facet |
Noel Lorenzo Villalba Emmanuel Andrés Alain Meyer |
author_sort |
Noel Lorenzo Villalba |
title |
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy |
title_short |
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy |
title_full |
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy |
title_fullStr |
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy |
title_full_unstemmed |
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy |
title_sort |
chronic onset form of anti-hmg-coa reductase myopathy |
publisher |
SMC MEDIA SRL |
series |
European Journal of Case Reports in Internal Medicine |
issn |
2284-2594 |
publishDate |
2021-06-01 |
description |
We report a case of anti-HMGCR myopathy mimicking limb-girdle muscular dystrophy in a 27-year-old male patient with no history of statin intake and presenting with a chronic onset form over 3 years. Treatment with prednisone and methotrexate was initiated with an insufficient response, so intravenous immunoglobulin was added. One year after initial treatment was started, as levels of creatine kinase (CK) were >1000 U/l, treatment with rituximab was added. Despite a 3-year delay before treatment, muscle strength improved even though CK levels remain elevated. |
url |
https://www.ejcrim.com/index.php/EJCRIM/article/view/2672 |
work_keys_str_mv |
AT noellorenzovillalba chroniconsetformofantihmgcoareductasemyopathy AT emmanuelandres chroniconsetformofantihmgcoareductasemyopathy AT alainmeyer chroniconsetformofantihmgcoareductasemyopathy |
_version_ |
1721313715803914240 |